The Biden administration issued its guidance last week to explain how it plans to implement price controls on pharmaceuticals, per the so-called “Inflation Reduction Act,” and it is even more outrageous than the law itself. The Centers for Medicare and Medicaid Services (CMS) released its first list of 27 drugs it will target for government price … [Read more...] about Freezing Innovation
Prescription Drugs
New Treatments for Obesity
by Grace-Marie Turner | Published March 20, 2023 at RealClearHealth | Obesity is a serious health problem for millions of Americans and for our nation where 42% of US adults are living with obesity. The association with other chronic conditions, including heart disease, stroke, and Type 2 diabetes, is incontrovertible. Obesity also has been identified as … [Read more...] about New Treatments for Obesity
The High Cost of Drug Price Controls
By Grace-Marie Turner | RealClearHealth | April 28, 2021 The debate over expanding government control of our health sector should have ended during the Covid-19 pandemic: Where there have been failures in responding to the crisis, it has been a failure of big government—such as the Center for Disease Control’s arrogant and clumsy insistence on controlling early development of testing … [Read more...] about The High Cost of Drug Price Controls
Double-dippers drive up drug costs
In searching for answers to why drug costs are high, we only need look at problems our own government has created. One of the biggest culprits distorting prices is the once obscure “340B Drug Pricing Program.” Created in 1992, it requires drugmakers to offer steep discounts to certain safety net clinics and hospitals to help them “stretch scarce federal resources.” The original intent was to … [Read more...] about Double-dippers drive up drug costs
Trump Doesn’t Need Price Controls to Lower Prescription Drug Costs
By making full use of his executive authority, President Donald Trump has helped to reduce health care costs by increasing choice and competition. But his recent executive order to base Medicare drug prices on rates set by foreign governments is a misstep. Instead of importing price controls, the Trump administration should pursue bipartisan Medicare reforms that would cap seniors’ … [Read more...] about Trump Doesn’t Need Price Controls to Lower Prescription Drug Costs
Budget Deal Landmines
Published on FORBES.com | The Trump administration and the Congress reportedly are close to a budget deal that would increase federal spending and also suspend the debt limit for two years. House Speaker Nancy Pelosi is personally engaged in the talks in an effort to reach a deal before the Congress leaves town for its August recess. As a sweetener, she says she will … [Read more...] about Budget Deal Landmines
HHS Marches Forward To Enhance Drug Price Transparency
Published on FORBES.com | HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to increase transparency and lower prescription drug prices since President Trump released his American Patients First blueprint in a Rose Garden ceremony a year ago. The blueprint offered nearly 30 policy recommendations to modernize … [Read more...] about HHS Marches Forward To Enhance Drug Price Transparency
GOP May Outflank Bernie on Drug Price Controls
Published on RealClearHealth.com | It wasn’t so long ago that Bernie Sanders (I-VT) comfortably occupied the left flank of health care policy. His Medicare For All bill was sufficiently costly, coercive and utopian to set him apart from the pack. Times have changed. When it comes to drug pricing, Bernie faces unexpected intruders on his left: Republicans. In recent months, Bernie … [Read more...] about GOP May Outflank Bernie on Drug Price Controls